Rehabilitation for Ataxia Following Chemotherapy for Burkitt Lymphoma Involving the Rectum
Hyoung-Seop KIM; Chul-Oh JUNG; Ha-Ra JEON; Lee-Ho SUNG.
Annals of Rehabilitation Medicine
; : 578-583, 2012.
Artículo
en Inglés
| WPRIM | ID: wpr-126702
Burkitt lymphoma is a type of B-cell lymphoma that occurs mostly in children, and rarely in adults. The sporadic type is known to occur mostly at the ileum and cecum. Cytarabine, which is used for central nervous system prophylaxis during chemotherapy for Burkitt lymphoma, has known neurotoxicity, and its side effects include motor ataxia due to cerebellar injury, ataxic dysarthria, dysfunction of ocular movement, confusion, somnolence and lethargy. This case report is about a patient diagnosed with Burkitt lymphoma who manifested motor ataxia after chemotherapy that included cytarabine.
Biblioteca responsable:
WPRO
Texto completo
Documentos relacionados